Cash flow ImmunityBio, Inc.

Stocks

IBRX

US45256X1037

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 21/07/2026 BST			Pre-market 14:12:51
8.070 ^USD	+7.67%		8.030	-0.50%

05-20	Exchange-Traded Funds, Equity Futures Advance Pre-Bell Wednesday Ahead of Nvidia Earnings Report	MT
05-20	ImmunityBio's Supplemental Biologics License Application for Anktiva Accepted by FDA	MT

a29a2e34c6fda44b33e20ccc128.eoeCP5-XRhNcsCznTJ8-bAqtIiomvSGMh3Tnc0zdXtU.AMHdDdGhMmUziXueC-hKJjuZRFJV6mK06EOLAXibOIUv8LFsrcM1cR2CdQ

Published financial data: IMMUNITYBIO, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	934K	240K	622K	14.15M	113M
Other Revenues, Total	-	-	-	595K	306K
Total Revenues	934K	240K	622K	14.74M	113M
Cost of Goods Sold, Total	-	-	-	-	753K
Gross Profit	934K	240K	622K	14.74M	113M
Selling General & Admin Expenses, Total	122M	103M	135M	173M	150M
R&D Expenses	196M	248M	227M	186M	219M
Other Operating Expenses, Total	318M	351M	362M	359M	369M
Operating Income	-317M	-351M	-361M	-344M	-256M
Interest Expense, Total	-14.85M	-63.52M	-129M	-154M	-113M
Interest And Investment Income	-	-	1.13M	7.98M	6.4M
Net Interest Expenses	-14.85M	-63.52M	-128M	-146M	-106M
Income (Loss) On Equity Invest.	-803K	-12.11M	-7.55M	-	-
Other Non Operating Income (Expenses)	193K	16.91M	-84.44M	77.52M	10.54M
EBT, Excl. Unusual Items	-333M	-409M	-581M	-413M	-352M
Merger & Related Restructuring Charges	-13M	-	-	-	-
Gain (Loss) On Sale Of Investments	-4.1M	-7.28M	-1.59M	-632K	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-681K	-886K	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	144K	51K	-1K	1K	-
EBT, Incl. Unusual Items	-350M	-417M	-584M	-414M	-352M
Income Tax Expense	9K	34K	-40K	-	-135K
Earnings From Continuing Operations	-350M	-417M	-584M	-414M	-351M
Net Income to Company	-350M	-417M	-584M	-414M	-351M
Minority Interest	3.06M	753K	656K	81K	74K
Net Income - (IS)	-347M	-417M	-583M	-414M	-351M
Net Income to Common Incl Extra Items	-347M	-417M	-583M	-414M	-351M
Net Income to Common Excl. Extra Items	-347M	-417M	-583M	-414M	-351M
Per Share Items
Net EPS - Basic	-0.89	-1.04	-1.15	-0.59	-0.38
Basic EPS - Continuing Operations	-0.89	-1.04	-1.15	-0.59	-0.38
Basic Weighted Average Shares Outstanding	389M	400M	509M	697M	920M
Net EPS - Diluted	-0.89	-1.04	-1.15	-0.62	-0.38
Diluted EPS - Continuing Operations	-0.89	-1.04	-1.15	-0.62	-0.38
Diluted Weighted Average Shares Outstanding	389M	400M	509M	700M	920M
Normalized Basic EPS	-0.53	-0.64	-0.71	-0.37	-0.24
Normalized Diluted EPS	-0.53	-0.64	-0.71	-0.37	-0.24
Supplemental Items
EBITDA	-303M	-332M	-343M	-327M	-241M
EBITA	-317M	-351M	-359M	-342M	-254M
EBIT	-317M	-351M	-361M	-344M	-256M
EBITDAR	-292M	-314M	-324M	-308M	-222M
Total Revenues (As Reported)	-	-	-	14.74M	113M
Effective Tax Rate - (Ratio)	-0	-0.01	0.01	-	0.04
Current Domestic Taxes	-9K	38K	-26K	-	4K
Total Current Taxes	-9K	38K	-26K	-	4K
Deferred Domestic Taxes	-	-4K	-14K	-	-139K
Total Deferred Taxes	-	-4K	-14K	-	-139K
Normalized Net Income	-205M	-255M	-363M	-258M	-220M
Interest on Long-Term Debt	-	-	-	154M	112M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	196M	248M	232M	190M	219M
Net Rental Expense, Total	10.84M	18.03M	18.73M	18.5M	18.58M
Imputed Operating Lease Interest Expense	2.8M	13.34M	24.07M	27.3M	20.47M
Imputed Operating Lease Depreciation	8.04M	4.69M	-5.33M	-8.8M	-1.89M
Stock-Based Comp., R&D Exp. (Total)	18.82M	11.67M	17.34M	12M	10.62M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	38.36M	28.51M	31.82M	22.43M	26.19M
Total Stock-Based Compensation	57.18M	40.18M	49.16M	34.43M	36.81M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	181M	105M	265M	143M	88.33M
Short Term Investments	136M	2.54M	1.01M	6.38M	154M
Total Cash And Short Term Investments	317M	107M	266M	150M	243M
Accounts Receivable, Total	-	-	-	2.36M	42.57M
Other Receivables	1.33M	1.89M	3.17M	293K	46K
Total Receivables	1.33M	1.89M	3.17M	2.65M	42.62M
Inventory	-	2.16M	-	8.27M	910K
Prepaid Expenses	15.9M	13.91M	12.87M	16.73M	16.85M
Other Current Assets, Total	-	15.44M	11.58M	7.12M	11.68M
Total Current Assets	334M	141M	294M	185M	315M
Gross Property Plant And Equipment	172M	259M	267M	270M	260M
Accumulated Depreciation	-53.07M	-69.25M	-84.38M	-99.59M	-112M
Net Property Plant And Equipment	119M	190M	183M	170M	148M
Long-term Investments	7.6M	5.56M	891K	-	14.21M
Goodwill	-	-	-	910K	910K
Other Intangibles, Total	1.42M	20M	17.09M	15.02M	13.04M
Loans Receivable Long-Term	6.38M	6.63M	6.88M	7.13M	7.38M
Other Long-Term Assets, Total	-	-	2.82M	4.83M	3.94M
Total Assets	469M	362M	504M	383M	502M
Liabilities
Accounts Payable, Total	11.42M	21.02M	9.2M	6.72M	6.98M
Accrued Expenses, Total	28.78M	34.26M	39.53M	37.91M	42.01M
Short-term Borrowings	299M	433M	1.48M	1.25M	1.75M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	3.01M	2.73M	5.31M	7.47M	7.59M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	26.55M	9.54M	2.77M	1.6M	3.42M
Total Current Liabilities	369M	501M	58.28M	54.94M	61.75M
Long-Term Debt	306M	241M	837M	746M	802M
Long-Term Leases	37.07M	48.02M	39.94M	34.82M	33.67M
Deferred Tax Liability Non Current	162K	-	-	-	-
Other Non Current Liabilities	249K	22.03M	155M	35.01M	104M
Total Liabilities	713M	812M	1.09B	871M	1B
Common Stock, Total	40K	42K	67K	85K	101K
Additional Paid In Capital	1.72B	1.93B	2.37B	2.88B	3.2B
Retained Earnings	-1.96B	-2.38B	-2.96B	-3.38B	-3.73B
Comprehensive Income and Other	4K	183K	10K	1.2M	28.96M
Total Common Equity	-242M	-447M	-587M	-489M	-500M
Minority Interest	-1.74M	-2.49M	1.05M	969K	895K
Total Equity	-244M	-450M	-586M	-488M	-500M
Total Liabilities And Equity	469M	362M	504M	383M	502M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	398M	436M	674M	853M	1.03B
ECS Total Common Shares Outstanding	398M	422M	671M	853M	1.01B
Book Value / Share	-0.61	-1.06	-0.87	-0.57	-0.49
Tangible Book Value	-244M	-467M	-604M	-505M	-514M
Tangible Book Value Per Share	-0.61	-1.11	-0.9	-0.59	-0.51
Total Debt	646M	725M	884M	790M	845M
Net Debt	328M	617M	616M	640M	602M
Debt Equivalent Oper. Leases	86.71M	144M	150M	148M	149M
Minority Interest, Total (Incl. Fin. Div)	-1.74M	-2.49M	1.05M	969K	895K
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Work In Process, Total	-	-	-	7.5M	-
Inventories - Finished Goods, Total	-	-	-	767K	-
Buildings, Total	-	-	-	-	-
Machinery, Total	55.34M	69.85M	71.8M	75.44M	65.13M
Full Time Employees	587	725	628	680	684
Part Time Employees	-	-	-	-	7

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-347M	-417M	-583M	-414M	-351M
Depreciation & Amortization - CF	14.24M	18.26M	16.51M	15.55M	13.42M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	2M	2M	2M
Depreciation & Amortization, Total	14.24M	18.26M	18.51M	17.55M	15.42M
Amortization of Deferred Charges, Total - (CF)	-	16.28M	42.4M	22.59M	100K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	4.62M	5.51M	1.45M	-857K	-2.74M
Asset Writedown & Restructuring Costs	-	2.01M	886K	-	14.02M
(Income) Loss On Equity Investments - (CF)	803K	-	-	-	-
Stock-Based Compensation (CF)	57.18M	40.18M	49.16M	34.43M	36.81M
Other Operating Activities, Total	14.65M	4.82M	100M	-31.97M	37.18M
Change In Accounts Receivable	-	-	-	-2.36M	-40.21M
Change In Inventories	-	-	-	-8.27M	-6.32M
Change In Accounts Payable	-3.72M	8M	-6.48M	-3.17M	-190K
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-15.4M	-16M	10.45M	-5.62M	-7.6M
Cash from Operations	-274M	-338M	-367M	-391M	-305M
Capital Expenditure	-33.56M	-78.16M	-30.58M	-6.89M	-3.85M
Sale of Property, Plant, and Equipment	20.5M	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-21.23M	-	-	-406K
Investment in Marketable and Equity Securities, Total	-71.82M	127M	114K	-5.36M	-146M
Cash from Investing	-84.89M	27.3M	-30.47M	-12.25M	-150M
Short Term Debt Issued, Total	-	-	-	-	2.88M
Long-Term Debt Issued, Total	338M	174M	451M	96.96M	-
Total Debt Issued	338M	174M	451M	96.96M	2.88M
Long-Term Debt Repaid, Total	-	-58K	-77K	-64K	-1.16M
Total Debt Repaid	-	-58K	-77K	-64K	-1.16M
Issuance of Common Stock	170M	60.5M	110M	190M	401M
Repurchase of Common Stock	-	-616K	-3.44M	-5.46M	-2.26M
Other Financing Activities, Total	-3.05M	-339K	-	-	-
Cash from Financing	505M	234M	558M	282M	400M
Foreign Exchange Rate Adjustments	48K	284K	-292K	-23K	15K
Net Change in Cash	146M	-76.32M	161M	-122M	-54.48M
Supplemental Items
Cash Interest Paid	2.11M	35.44M	77.19M	92.32M	71.32M
Cash Income Tax Paid (Refund)	9K	2K	8K	15K	-
Levered Free Cash Flow	-168M	-299M	-235M	-256M	-213M
Unlevered Free Cash Flow	-158M	-276M	-196M	-182M	-143M
Change In Net Working Capital	-2.05M	15.5M	7.54M	12.42M	31.09M
Net Debt Issued / Repaid	338M	174M	451M	96.89M	1.72M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-57.48	-52.73	-52.11	-48.48	-36.17
Return on Total Capital	-71	-64.47	-78.8	-71.77	-49.48
Return On Equity %	193.07	120.31	112.74	77.02	71.17
Return on Common Equity	191.61	120.83	112.77	76.86	71.02
Margin Analysis
Gross Profit Margin %	100	100	100	100	99.34
SG&A Margin	13.09K	42.8K	21.76K	1.18K	132.41
EBITDA Margin %	-32.46K	-139K	-55.12K	-2.22K	-212.38
EBITA Margin %	-33.99K	-146K	-57.78K	-2.32K	-224.23
EBIT Margin %	-33.99K	-146K	-58.1K	-2.33K	-226
Income From Continuing Operations Margin %	-37.46K	-174K	-93.87K	-2.81K	-310.25
Net Income Margin %	-37.13K	-174K	-93.76K	-2.8K	-310.18
Net Avail. For Common Margin %	-37.13K	-174K	-93.76K	-2.8K	-310.18
Normalized Net Income Margin	-21.95K	-106K	-58.32K	-1.75K	-193.91
Levered Free Cash Flow Margin	-17.96K	-125K	-37.73K	-1.74K	-188.33
Unlevered Free Cash Flow Margin	-16.97K	-115K	-31.56K	-1.24K	-126.25
Asset Turnover
Asset Turnover	0	0	0	0.03	0.26
Fixed Assets Turnover	0.01	0	0	0.08	0.71
Receivables Turnover (Average Receivables)	-	-	-	-	5.03
Inventory Turnover (Average Inventory)	-	-	-	-	0.16
Short Term Liquidity
Current Ratio	0.91	0.28	5.05	3.36	5.1
Quick Ratio	0.86	0.22	4.63	2.77	4.62
Operating Cash Flow to Current Liabilities	-0.74	-0.67	-6.29	-7.12	-4.94
Days Sales Outstanding (Average Receivables)	-	-	-	-	72.58
Days Outstanding Inventory (Average Inventory)	-	-	-	-	2.23K
Average Days Payable Outstanding	-	-	-	-	-378.39
Cash Conversion Cycle (Average Days)	-	-	-	-	2.68K
Long Term Solvency
Total Debt/Equity	-264.71	-161.25	-150.81	-161.81	-169.09
Total Debt / Total Capital	160.71	263.27	296.79	261.8	244.74
LT Debt/Equity	-140.79	-64.31	-149.66	-160.02	-167.22
Long-Term Debt / Total Capital	85.48	105	294.52	258.91	242.04
Total Liabilities / Total Assets	152.02	224.14	216.15	227.47	199.54
EBIT / Interest Expense	-21.38	-5.52	-2.8	-2.23	-2.28
EBITDA / Interest Expense	-19.69	-4.95	-2.51	-2	-1.97
(EBITDA - Capex) / Interest Expense	-21.95	-6.18	-2.75	-2.04	-2.01
Total Debt / EBITDA	-2.21	-2.31	-2.73	-2.56	-3.8
Net Debt / EBITDA	-1.12	-1.96	-1.9	-2.08	-2.71
Total Debt / (EBITDA - Capex)	-1.98	-1.85	-2.49	-2.51	-3.74
Net Debt / (EBITDA - Capex)	-1.01	-1.57	-1.74	-2.03	-2.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.38	-74.3	159.17	2.27K	668.31
Gross Profit, 1 Yr. Growth %	54.38	-74.3	159.17	2.27K	663.21
EBITDA, 1 Yr. Growth %	61.33	9.64	3.14	-4.73	-26.34
EBITA, 1 Yr. Growth %	58.18	10.47	3.04	-4.78	-25.76
EBIT, 1 Yr. Growth %	58.18	10.47	3.05	-4.75	-25.61
Earnings From Cont. Operations, 1 Yr. Growth %	56.05	19.29	39.91	-29.15	-15.03
Net Income, 1 Yr. Growth %	56.32	20.12	40	-29.09	-15.03
Normalized Net Income, 1 Yr. Growth %	63.44	26.22	42.19	-28.86	-14.87
Diluted EPS Before Extra, 1 Yr. Growth %	51.01	16.92	10.07	-46.19	-38.27
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	1.7K
Inventory, 1 Yr. Growth %	-	-	-	-	-89
Net Property, Plant and Equip., 1 Yr. Growth %	31.42	59.09	-3.64	-6.69	-13.44
Total Assets, 1 Yr. Growth %	111.81	-22.72	39.21	-24.09	31.07
Tangible Book Value, 1 Yr. Growth %	100.87	91.85	29.26	-16.4	1.86
Common Equity, 1 Yr. Growth %	102.13	84.71	31.22	-16.68	2.32
Cash From Operations, 1 Yr. Growth %	59.8	22.99	8.67	6.67	-22.06
Capital Expenditures, 1 Yr. Growth %	1.91K	132.88	-60.87	-77.48	-44.16
Levered Free Cash Flow, 1 Yr. Growth %	77.43	75.59	-21.53	9.23	-16.76
Unlevered Free Cash Flow, 1 Yr. Growth %	78.31	71.1	-28.78	-7.06	-21.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-34.87	-37.02	-18.39	683.82	1.25K
Gross Profit, 2 Yr. CAGR %	-34.87	-37.02	-18.39	683.82	1.25K
EBITDA, 2 Yr. CAGR %	45.98	32.99	6.34	-0.87	-16.23
EBITA, 2 Yr. CAGR %	42.5	32.19	6.4	-0.95	-15.92
EBIT, 2 Yr. CAGR %	42.5	32.19	6.7	-0.93	-15.83
Earnings From Cont. Operations, 2 Yr. CAGR %	47.8	36.44	29.18	-0.44	-22.41
Net Income, 2 Yr. CAGR %	48.26	37.03	29.68	-0.36	-22.38
Normalized Net Income, 2 Yr. CAGR %	44.76	41.6	33.97	0.58	-22.18
Diluted EPS Before Extra, 2 Yr. CAGR %	43.83	33.06	13.44	-22.92	-42.36
Inventory, 2 Yr. CAGR %	-	-	-	95.69	-
Net Property, Plant and Equip., 2 Yr. CAGR %	107.13	44.59	23.81	-5.18	-10.13
Total Assets, 2 Yr. CAGR %	94.82	27.94	3.72	2.8	-0.25
Tangible Book Value, 2 Yr. CAGR %	43.31	96.31	57.48	3.96	-7.72
Common Equity, 2 Yr. CAGR %	50.77	93.23	55.69	4.56	-7.66
Cash From Operations, 2 Yr. CAGR %	34.32	40.19	15.61	7.67	-8.82
Capital Expenditures, 2 Yr. CAGR %	179.8	584.34	-4.54	-70.31	-64.54
Levered Free Cash Flow, 2 Yr. CAGR %	24.55	77.84	17.38	-7.42	-4.65
Unlevered Free Cash Flow, 2 Yr. CAGR %	23.18	76.09	10.39	-18.64	-14.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-33.37	-52.23	0.93	150.86	678.62
Gross Profit, 3 Yr. CAGR %	-33.37	-52.23	0.93	150.86	676.89
EBITDA, 3 Yr. CAGR %	64.3	32.69	22.19	2.51	-10.21
EBITA, 3 Yr. CAGR %	63.28	30.91	21.44	2.54	-10.03
EBIT, 3 Yr. CAGR %	63.28	30.91	21.66	2.73	-9.95
Earnings From Cont. Operations, 3 Yr. CAGR %	59.53	37.61	37.58	5.74	-5.56
Net Income, 3 Yr. CAGR %	60.44	38.21	38.01	6.05	-5.51
Normalized Net Income, 3 Yr. CAGR %	63.49	37.64	41.8	8.49	-4.86
Diluted EPS Before Extra, 3 Yr. CAGR %	50.79	34.23	24.91	-11.44	-28.42
Inventory, 3 Yr. CAGR %	-	-	-	-	-25.03
Net Property, Plant and Equip., 3 Yr. CAGR %	59.03	89.69	26.3	12.67	-8.02
Total Assets, 3 Yr. CAGR %	50.44	43.15	31.59	-6.53	11.47
Tangible Book Value, 3 Yr. CAGR %	57.22	57.94	70.78	27.51	3.25
Common Equity, 3 Yr. CAGR %	68.52	61.33	69.84	26.4	3.81
Cash From Operations, 3 Yr. CAGR %	60.22	30.43	28.78	12.55	-3.33
Capital Expenditures, 3 Yr. CAGR %	53.14	163.2	163.64	-41.01	-63.36
Levered Free Cash Flow, 3 Yr. CAGR %	-	40.35	35.39	14.6	-10.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	38.19	30.23	4.24	-19.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-27.74	46.27	184.76
Gross Profit, 5 Yr. CAGR %	-	-	-27.74	46.27	184.38
EBITDA, 5 Yr. CAGR %	-	-	38.06	18.08	5.07
EBITA, 5 Yr. CAGR %	-	-	37.57	16.96	4.83
EBIT, 5 Yr. CAGR %	-	-	37.73	17.1	4.99
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	46.62	20.9	9.41
Net Income, 5 Yr. CAGR %	-	-	47.35	21.26	9.63
Normalized Net Income, 5 Yr. CAGR %	-	-	50.54	21.41	11.54
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	34.57	7.52	-8.28
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	43.88	43.74	10.23
Total Assets, 5 Yr. CAGR %	-	-	29.65	25.39	17.79
Tangible Book Value, 5 Yr. CAGR %	-	-	57.32	33.61	33.51
Common Equity, 5 Yr. CAGR %	-	-	63.27	35.64	33.1
Cash From Operations, 5 Yr. CAGR %	-	-	40.61	20.8	12.17
Capital Expenditures, 5 Yr. CAGR %	-	-	26.76	9.95	18.17
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	18.84	17.68
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	11.8	9.98